Redcliffe Lifetech Bags $61 M From LeapFrog Investments, Others
Redcliffe plans to use the new funds to expand its geographic reach into tier II and III cities, according to the company
Photo Credit : cloudfront.net,
LeapFrog Investments led a $ 61 million Series B investment for omnichannel diagnostics platform Redcliffe Lifetech, with participation from Healthquad, Schroders, LC Nueva, Growth Spark Ventures, and prior investors Chiratae Ventures and Alkemi Venture Partners.
Redcliffe plans to use the new funds to expand its geographic reach into tier II and III cities, according to the company.
The company has a fleet of 400 phlebotomists working in over 100 locations, collecting samples at customers' homes, as well as an offline network of 500 collection centers.
According to the firm, these services are 25-60 percent less expensive than typical competitors.
Tags assigned to this article:
LeapFrog Investments
omnichannel diagnostics platform
Redcliffe Lifetech
HealthQuad
Schroders
LC Nueva
Growth Spark Ventures
Chiratae Ventures
Alkemi Venture Partners
